{"entity":"astrazeneca","id":"ent_astrazeneca","name":"AstraZeneca","wikidata":"Q731938","page":"https://asof.is/record/astrazeneca","summary":"AstraZeneca is a British-Swedish pharmaceutical company, headquartered in Cambridge. It reported revenue of $58.74B for the period ended December 31, 2025.","title":"AstraZeneca: revenue $58.74B","key_facts":[{"label":"Headquarters","value":"Cambridge","claim":"clm_6B4DC8E0E36A"},{"label":"Revenue","value":"$58.74B","recorded":"58,739,000,000 United States dollar","note":"to 2025-12-31","claim":"clm_75285D1846DF"},{"label":"Ticker","value":"AZN · NYSE","claim":"clm_7F36A4D2B72F"}],"faq":[{"question":"Where is AstraZeneca headquartered?","answer":"Cambridge."},{"question":"What is AstraZeneca's revenue?","answer":"$58.74B for the period ended December 31, 2025."}],"as_of":"2026-11-08","known_by":null,"since":null,"fact_pages":[{"predicate":"headquarters","page":"https://asof.is/record/astrazeneca/headquarters","md":"https://asof.is/record/astrazeneca/headquarters.md","json":"https://asof.is/v1/entities/astrazeneca/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/astrazeneca/revenue","md":"https://asof.is/record/astrazeneca/revenue.md","json":"https://asof.is/v1/entities/astrazeneca/revenue"},{"predicate":"net_income","page":"https://asof.is/record/astrazeneca/net_income","md":"https://asof.is/record/astrazeneca/net_income.md","json":"https://asof.is/v1/entities/astrazeneca/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/astrazeneca/operating_income","md":"https://asof.is/record/astrazeneca/operating_income.md","json":"https://asof.is/v1/entities/astrazeneca/operating_income"}],"products":[],"coverage":{"entity":"astrazeneca","name":"AstraZeneca","kind":"organization","sources":[{"source":"wikidata","item":"Q731938","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":901832,"ticker":"AZN","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":65,"open":13,"retracted":0,"first":"1995-03-13","predicates":{"total_assets":{"claims":11,"open":1,"kind":"fact"},"revenue":{"claims":11,"open":1,"kind":"fact"},"operating_income":{"claims":11,"open":1,"kind":"fact"},"net_income":{"claims":11,"open":1,"kind":"fact"},"total_equity":{"claims":12,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"cik":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":65,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_8820826D4245","predicate":"cik","value":"0000901832","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca cik: 0000901832\", undated. Claim clm_8820826D4245, https://asof.is/claim/clm_8820826D4245, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_8820826D4245","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_433F982364C7","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca fiscal year end: 12-31\", undated. Claim clm_433F982364C7, https://asof.is/claim/clm_433F982364C7, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_433F982364C7","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_6B4DC8E0E36A","predicate":"headquarters","value":"Cambridge","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca headquarters: Cambridge\", undated. Claim clm_6B4DC8E0E36A, https://asof.is/claim/clm_6B4DC8E0E36A, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_6B4DC8E0E36A","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_43376D897A1F","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca listed on: NYSE\", undated. Claim clm_43376D897A1F, https://asof.is/claim/clm_43376D897A1F, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_43376D897A1F","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7F0BFE9EB1CD","predicate":"net_income","value":"10,233,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca net income: 10,233,000,000 United States dollar\", as of 2025-12-31. Claim clm_7F0BFE9EB1CD, https://asof.is/claim/clm_7F0BFE9EB1CD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_7F0BFE9EB1CD","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-24"}},{"id":"clm_763AA2791DE9","predicate":"operating_income","value":"13,743,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca operating income: 13,743,000,000 United States dollar\", as of 2025-12-31. Claim clm_763AA2791DE9, https://asof.is/claim/clm_763AA2791DE9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_763AA2791DE9","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-24"}},{"id":"clm_CC0A4381A0A0","predicate":"registrant_name","value":"ASTRAZENECA PLC","valid_from":"1999-02-05","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca registrant name: ASTRAZENECA PLC\", as of 1999-02-05. Claim clm_CC0A4381A0A0, https://asof.is/claim/clm_CC0A4381A0A0, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_CC0A4381A0A0","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_75285D1846DF","predicate":"revenue","value":"58,739,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca revenue: 58,739,000,000 United States dollar\", as of 2025-12-31. Claim clm_75285D1846DF, https://asof.is/claim/clm_75285D1846DF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_75285D1846DF","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Revenue in 20-F FY2025, filed 2026-02-24"}},{"id":"clm_26C4F27CEF84","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_26C4F27CEF84, https://asof.is/claim/clm_26C4F27CEF84, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_26C4F27CEF84","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_8352C183E226","predicate":"state_of_incorporation","value":"X0","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca state of incorporation: X0\", undated. Claim clm_8352C183E226, https://asof.is/claim/clm_8352C183E226, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_8352C183E226","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7F36A4D2B72F","predicate":"ticker","value":"AZN","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca ticker: AZN\", undated. Claim clm_7F36A4D2B72F, https://asof.is/claim/clm_7F36A4D2B72F, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832.","url":"https://asof.is/claim/clm_7F36A4D2B72F","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_B12E0C1D9275","predicate":"total_assets","value":"114,074,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca total assets: 114,074,000,000 United States dollar\", as of 2025-12-31. Claim clm_B12E0C1D9275, https://asof.is/claim/clm_B12E0C1D9275, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_B12E0C1D9275","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-24"}},{"id":"clm_327B10FB292B","predicate":"total_equity","value":"48,719,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca total equity: 48,719,000,000 United States dollar\", as of 2025-12-31. Claim clm_327B10FB292B, https://asof.is/claim/clm_327B10FB292B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm.","url":"https://asof.is/claim/clm_327B10FB292B","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-24"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}